PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
57.43
ESG score 90-95% of Biotechnology median of 61.62. John Neff would demand higher returns to compensate for below-average ESG risk management.
53.84
Environmental score 90-95% of Biotechnology median of 57.28. John Neff would demand higher returns to compensate for below-average climate risk management.
59.54
Social score 90-95% of Biotechnology median of 64.75. John Neff would demand higher returns to compensate for below-average stakeholder management.
58.92
Governance score 90-95% of Biotechnology median of 62.58. John Neff would demand higher returns to compensate for below-average governance oversight.